Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity

Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity

US Patent 9850489 · Granted Dec 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sting agonists for treating bladder cancer and solid tumors2024
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell 2022
Sting agonists for treating bladder cancer and solid tumors2021
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-22019
Methods and reagents that specifically detect, distinguish and quantify IFN-LAMB2018
Methods and reagents that specifically detect, distinguish and quantify IFN-LAMB2018
Methods and reagents that specifically detect, distinguish and quantify IFN-LAMB2018
Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and met2018
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell 2017
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor2016
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor2016
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-2016